The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Nonnarcotic Analgesic Use and the Risk of Hypertension in US Women
Open accessAbstract
Acetaminophen, aspirin, and other nonsteroidal anti-inflammatory drugs (NSAIDs) are widely consumed. Each is theoretically capable of elevating blood pressure by altering prostaglandin homeostasis; however, there is little prospective information on the relation between these agents and physician-diagnosed hypertension. We examined the association between the use of aspirin, acetaminophen, or NSAIDs and incident hypertension in a prospective cohort study of 51 630 women 44 to 69 years of age in 1990 who had no history of hypertension or chronic renal insufficiency. Analgesic use was assessed in 1990 by a mailed questionnaire, and the women were followed for 8 years. The primary outcome was physician-diagnosed hypertension reported on a follow-up biennial questionnaire. During 381 078 person-years of follow-up, 10 579 incident cases of hypertension were identified. Compared with nonusers, women who used aspirin or acetaminophen at least 1 day per month or NSAIDs 5 or more days per month were at a significantly higher risk for development of hypertension. After adjusting for potential confounders, the odds ratios for women in the highest frequency of use category (≥22 days per month) compared with no use were as follows: aspirin, 1.21 (95% CI, 1.13 to 1.30); acetaminophen, 1.20 (1.08 to 1.33); and NSAIDs, 1.35 (1.25 to 1.46). For each analgesic type, there was a significant trend toward an increased risk of incident hypertension with increasing frequency of use ( P <0.001). Given the observed odds ratios, biologic plausibility, and the sizeable population at risk, health professionals should consider potential hypertensive effects of aspirin, acetaminophen, and NSAIDs when counseling their patients about the use of nonnarcotic analgesics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“With their widespread use, NSAIDs are considered one of the most common offending agents affecting BP control.180,181”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [180]
Citations
Cites
Burt, V. L., Whelton, P., Roccella, E. J., Brown, C., Cutler, J. A., Higgins, M., Horan, M. J., & Labarthe, D. (1995) · Hypertension · doi:10.1161/01.hyp.25.3.305 · Cited by 2,998
Acetylation of prostaglandin synthase by aspirin.
Roth, G. J., Stanford, N., & Majerus, P. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.8.3073 · Cited by 1,012
COLDITZ, G. A., MARTIN, P., STAMPFER, M. J., WILLETT, W. C., SAMPSON, L., ROSNER, B., HENNEKENS, C. H., & SPEIZER, F. E. (1986) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114319 · Cited by 992
Self-citationDo Nonsteroidal Anti-inflammatory Drugs Affect Blood Pressure? A Meta-Analysis
Johnson, A. G., Nguyen, T. V., & Day, R. O. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-4-199408150-00011 · Cited by 717
A Meta-analysis of the Effects of Nonsteroidal Anti-inflammatory Drugs on Blood Pressure
Pope, J. E. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410040045007 · Cited by 527
Laneuville, O., Breuer, D. K., DeWitt, D. L., Hla, T., Funk, C. D., & Smith, W. L. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23861-7 · Cited by 472
Stokes, J. B., & Kokko, J. P. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108733 · Cited by 345
Effects of Sulindac and Ibuprofen in Patients with Chronic Glomerular Disease
Ciabattoni, G., Cinotti, G. A., Pierucci, A., Simonetti, B. M., Manzi, M., Pugliese, F. R., Barsotti, P., Pecci, G., Taggi, F., & Patrono, C. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402023100502 · Cited by 329
Initiation of Antihypertensive Treatment During Nonsteroidal Anti-inflammatory Drug Therapy
Gurwitz, J. H. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520100043031 · Cited by 220
Research works printed but not linked: 3
- Kaufman DW, Kelly JP, Anderson TE, Rosenberg L, Mitchell AA. A comprehensive population-based survey of medication use in the United States: the adult population. Pharmacoepidemiol Drug Saf. 2000; 9: S60.
- Colditz GA. The nurses’ health study: a cohort of US women followed since 1976. J Am Med Womens Assoc. 1995; 50: 40–44.
- Cinotti GA, Pugliese F. Prostaglandins in blood pressure regulation. Kidney Int Suppl. 1988; 25: S57–S60.
Cited by
Sorted by citations
Items 101–145 of 145
Treating Pain and Inflammation in Hypertension
White, W. B., Marfatia, R., & Baker, W. L. (2012) · Springer eBooks · doi:10.1007/978-88-470-2601-8_28 · Cited by 2
Ferdinand, K. C., Giles, T. D., Falkner, B. E., Toto, R. D., White, A. J., Cushman, W. C., White, W. B., Calhoun, A. W., Jones, D. W., Textor, S. C., et al. (2008) · Cited by 2
Minor and Short-Acting Analgesics, Including Opioid Combination Products
Stanos, S. P., & Tyburski, M. D. (2008) · Elsevier eBooks · doi:10.1016/b978-032304184-3.50035-2 · Cited by 3
Berbari, A. E., Daouk, N. A., & Jurjus, A. R. (2017) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-59918-2_43 · Cited by 3
Hypertension and Analgesic Intake: Light and Shade on an Old Problem
Camafort, M., & Coca, A. (2010) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(10)70058-x · Cited by 2
Response to: ‘Paracetamol: is all the concern valid?’ by Schwarz and Mullins
Roberts, E., & Conaghan, P. G. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207691 · Cited by 2
A Model on the Induction of Adverse Vascular Long-Term Effects of NSAIDs
Liedtke, R. (2009) · Medicinal Chemistry · doi:10.2174/157340609787049235 · Cited by 2
Mauwloudi, A., Eslamian, L., Marsousi, V., Jamal, A. S., Noorzadeh, M., Naemi, M., Norouzi, A. R., & Mesbah, N. (2024) · Journal of Obstetrics Gynecology and Cancer Research · doi:10.30699/jogcr.9.1.1 · Cited by 1
Riociguat as a treatment regime for pulmonary arterial hypertension: a review
Narang, B., Roy, S. D., Sharma, R. K., Singh, V., & Rawal, R. K. (2014) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2014.960976 · Cited by 1
Safety Profile of Current OA Therapies: Evidence from Clinical Trials
Perruccio, A. V., & Chandran, V. (2015) · Springer eBooks · doi:10.1007/978-3-319-19560-5_11 · Cited by 1
Habitual Caffeine Intake and the Risk of Hypertension in Women
Elliott, W. J. (2006) · Yearbook of Cardiology · doi:10.1016/s0145-4145(07)70016-3 · Cited by 1
Biology and Therapeutic Targeting of Prostanoids
Crofford, L. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-31696-5.00059-0 · Cited by 1
Aspirin as an Independent Risk Factor for Hypertension
Sanyaolu, A. O., Hammoudi, D., Meer, K., Zulfiqar, S., Varghese, N., Holmes, B., Pandit, R., & Sanyaolu, A. (2024) · Bioequivalence & Bioavailability International Journal · doi:10.23880/beba-16000233 · Cited by 1
Non-Steroidal Anti-Inflammatory Drugs and Chronic Kidney Disease
Clive, D. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411602-3.00057-3 · Cited by 1
NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AND HYPERTENSION – DOES AN EXEPTION CHANGE THE RULE?
Velickovic, D., Đukić, D., & Tasić, D. (2014) · Acta Medica Medianae · doi:10.5633/amm.2014.0304 · Cited by 1
Gouvêa-Silva, J. G., Ribeiro, B. L., Ygor, J. R., & Jose, C. D. S. A. (2021) · International Journal of Pharmaceutical Sciences and Developmental Research · doi:10.17352/ijpsdr.000033 · Cited by 1
Marcus, D. A. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-465-4_19 · Cited by 1
Popa, M. (2011) · ScholarWorks (Walden University) · Cited by 1
Le paracétamol est-il un médicament anodin en rhumatologie ?
Richette, P. (2013) · Revue du Rhumatisme · doi:10.1016/j.rhum.2013.10.004 · Cited by 1
Bannwarth, B. (2007) · EMC - Appareil locomoteur · doi:10.1016/s0246-0521(07)43670-1 · Cited by 1
Emerging therapies in the management of hypertensive patients with osteoarthritis
Gentile, G., Angeli, F., Mazzotta, G., Reboldi, G., & Verdecchia, P. (2011) · Clinical Investigation · doi:10.4155/cli.10.8 · Cited by 1
Manolis, A. J. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734299250.793571584 · Cited by 1
Semplicini, A., Stella, F., & Ceolotto, G. (2012) · InTech eBooks · doi:10.5772/30352
PREDNOSTI PARACETAMOLA U LIJEČENJU OSOBA S HIPERTONIJOM I ARTROZOM
Pavličević, I., Kuzmanić, M., Rumboldt, M., & Rumboldt, Z. (2011) · University of Zagreb University Computing Centre (SRCE)
Camps, M. B., Fernández, T. U., Díaz, R. M., Vilaubí, J. M. P., Cabello, M. I. E., & Doménech, C. S. (2008) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/s1134-2072(08)70780-1
¿Interfiere en el control de la HTA el consumo de paracetamol en formulaciones solubles?
Camps, M. B., Boreu, Q. F., Llibre, J. B., & de Tuero, G. C. (2010) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2009.03.003
Bannwarth, B. (2007) · EMC - Aparato Locomotor · doi:10.1016/s1286-935x(07)70954-1
Le paracétamol dans le traitement symptomatique des douleurs de l'arthrose
Bertin, P., Keddad, K., & Jolivet-Landreau, I. (2004) · Revue du Rhumatisme · doi:10.1016/s1169-8330(04)90001-4
Giles, T. D., Falkner, B. E., White, A. J., Cushman, W. C., White, W. B., Sica, D. A., Ferdinand, K. C., Calhoun, D. A., Jones, D. W., Textor, S. C., et al. (2013)
Letters to the Editor: New drugs - ziprasidone
Canny, L. M. (2007) · Australian Prescriber · doi:10.18773/austprescr.2007.036
Letters to the Editor: Managing hepatitis C in the community
Moro, P. (2007) · Australian Prescriber · doi:10.18773/austprescr.2007.037
Letters to the Editor: Should beta blockers remain first-line drugs for hypertension?
French, J. (2007) · Australian Prescriber · doi:10.18773/austprescr.2007.034
Letters to the Editor: Paracetamol
Vivian, D. (2007) · Australian Prescriber · doi:10.18773/austprescr.2007.035
Letters to the Editor: Can we deny patients expensive drugs?
Gallego, G., & Gool, K. V. (2007) · Australian Prescriber · doi:10.18773/austprescr.2007.033
Marcus, D. A. (2005) · Humana Press eBooks · doi:10.1385/1-59259-882-x:269
Общие принципы лечения скелетно-мышечно й боли: междисциплинарны й консенсус
Nasonov, E. L., Yakhno, N. N., Karateev, A. E., Алексеева, Л. И., Barinov, A. N., Барулин, А. Е., Давыдов, О. С., Danilov, A. B., Zhuravleva, M. V., Zavodovsky, B. V., et al. (2016)
Анальгетическое лечение с использованием системного алгоритма
Karateev, A. E., Алексеева, Л. И., & Насонова, В. А. (2015)
Analgesic Use and Hypertension Risk in Women
Gore, J. M. (2003) · Journal watch · doi:10.1056/jc200301310000005
Nishizaka, M., & Calhoun, D. A. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3358-5.50042-5
Beizer, J. L., & Davidson, E. H. (2006) · The Consultant Pharmacist · doi:10.4140/tcp.n.2006.147
Effect of chronic paracetamol treatment on the alteration of learning and memory in rats
Lalert, L., le grand, S. M., Srikiatkhachorn, A., & Saguanrungsirikul, S. (2018) · doi:10.58837/chula.the.2018.353
Chronic paracetamol treatment induces neuroinflammation and microglia activation in rat hippocampus
Lalert, L. (2021) · Chulalongkorn Medical Journal · doi:10.58837/chula.cmj.65.3.1
NSAIDs and Cardiovascular Toxicity
Baker, W. L., Bessada, Y., & Doyno, C. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00074-7
Rogers, P., Wang, D., Lu, Z., & Lyn‐Cook, B. D. (2024) · Journal of Women s Health · doi:10.1089/jwh.2023.1039
Effect of paracetamol on blood pressure and comparison with NSAIDs
Prokeš, M., & Suchopár, J. (2024) · Medicína pro praxi · doi:10.36290/med.2024.030
Metadata
- Authors
- Dedier, J., Stampfer, M. J., Hankinson, S. E., Willett, W. C., Speizer, F. E., & Curhan, G. C.
- Affiliations
- Brigham and Women's Hospital (US)
- Venue
- Hypertension
- Published
- 2002-11
- Volume
- 40
- Issue
- 5
- Pages
- 604-608
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2080325388
- Cited by
- 145
- References
- 23
- Citations by year
- 2025: 1 · 2024: 6 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 5 · 2018: 5 · 2017: 4 · 2016: 6 · 2015: 10 · 2014: 6 · 2013: 8 · 2012: 7
- FWCI
- 4.44
- Type
- journal article
- Language
- en
- Open access
- green
- nrs.harvard.edu
- Licence
- cc-by
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- National Cancer Institute (CA-87969, P01CA087969)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK052866, DK52866)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- non-opioid analgesics, aspirin, paracetamol, nonsteroidal anti-inflammatory drugs, blood pressure, prostaglandins, women, drug safety, incident hypertension risk
- MeSH terms
- Acetaminophen, Adult, Aged, Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Blood Pressure, Female, Follow-Up Studies, Humans, Hypertension, Middle Aged, Nurses, Prospective Studies, Surveys and Questionnaires, Risk, Risk Factors, United States, Cohort Studies, Incidence, Multivariate Analysis, Odds Ratio, Analgesics, Non-Narcotic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review